Literature DB >> 15463838

Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects.

José Luis Lezana1, Mario H Vargas, José Karam-Bechara, Ruth S Aldana, María E Y Furuya.   

Abstract

Sweat test is the standard for cystic fibrosis (CF) diagnosis. Conductivity is an alternative method not yet approved, in spite of its good correlation with chloride concentration. The aim was to assess the capacity of sweat conductivity to discriminate between CF and non-CF subjects. Automated measurements of conductivity and chloride concentration were carried out on the same sweat samples from subjects with clinical suspicion of CF. Sweat samples from 3,834 subjects, median age 1.8 years (range 1 month-54 years) were analysed, and those with chloride titration >60 mmol/l were considered as CF patients (n=294). Conductivity median values in CF and non-CF subjects were 111 mmol/l (82-148) and 36 mmol/l (12-89), respectively. The Spearman correlation between chloride titration and conductivity was r=0.60 (P<0.001). The receiver operating characteristics (ROC) curve showed very high agreement between two methods. The best conductivity cut-off value to diagnose CF was > or =90 mmol/l (sensitivity 99.7%, specificity 100%, positive and negative predictive values of 100% and 99.97%, respectively, and kappa=0.998). Likewise, the best conductivity cut-off value to exclude CF was <75 mmol/l. The sweat conductivity method showed good correlation with chloride titration, and accurately discriminated between subjects with and without CF. In accordance with this, CF diagnosis might be confirmed for conductivity values > or =90 mmol/l and excluded for <75 mmol/l. Values between 75 and 89 mmol/l should correspond to an equivocal range. However, more studies are needed to confirm the role of conductivity in definitive CF diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15463838     DOI: 10.1016/S1569-1993(02)00146-7

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

1.  Sweat chloride levels in asthma.

Authors:  Anirban Mandal; S K Kabra
Journal:  Indian J Pediatr       Date:  2014-12-28       Impact factor: 1.967

2.  Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.

Authors:  Annette Vernooij-van Langen; Edward Dompeling; Jan-Bart Yntema; Bert Arets; Harm Tiddens; Gerard Loeber; Jeannette Dankert-Roelse
Journal:  Eur J Pediatr       Date:  2015-02-13       Impact factor: 3.183

Review 3.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

4.  Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.

Authors:  Issa Siryani; Mohamed Jama; Nisreen Rumman; Hiyam Marzouqa; Moein Kannan; Elaine Lyon; Musa Hindiyeh
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

6.  Sweat test and cystic fibrosis: overview of test performance at public and private centers in the state of São Paulo, Brazil.

Authors:  Maria Fátima Servidoni; Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Adyléia Aparecida Dalbo Contrera Toro; Maria Ângela Gonçalves de Oliveira Ribeiro; José Dirceu Ribeiro; Antônio Fernando Ribeiro
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

Review 7.  Processing Newborn Bloodspot Screening Results for CF.

Authors:  Jürg Barben; Jane Chudleigh
Journal:  Int J Neonatal Screen       Date:  2020-03-25

8.  Nanoduct sweat conductivity measurements in 2664 patients: relationship to age, arterial blood gas, serum electrolyte profiles and clinical diagnosis.

Authors:  Rabia Gonul Sezer; Gokhan Aydemir; Abdullah Baris Akcan; Cem Paketci; Abdulbaki Karaoglu; Secil Aydinoz; Abdulkadir Bozaykut
Journal:  J Clin Med Res       Date:  2013-01-11

9.  Self-powered smart patch for sweat conductivity monitoring.

Authors:  Laura Ortega; Anna Llorella; Juan Pablo Esquivel; Neus Sabaté
Journal:  Microsyst Nanoeng       Date:  2019-01-28       Impact factor: 7.127

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.